Qube Research & Technologies LTD Beam Therapeutics Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 593,815 shares of BEAM stock, worth $10 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
593,815Holding current value
$10 Million% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding BEAM
# of Institutions
247Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$169 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$164 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$149 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$129 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.73MShares$79.7 Million0.05% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.19B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...